Metabolic syndrome in rheumatoid arthritis: role of adiponectin (preliminary results)
The clinical value of the disorders and diseases integrated within the metabolic syndrome (MS) is in the combination of traditional risk factors for cardiovascular diseases (CVD), which significantly accelerates the development of cardiovascular events (CVEs). The detection rate for MS in patients w...
Saved in:
| Main Authors: | Yulia Nikolaevna Gorbunova, T V Popkova, L V Kondratyeva, D S Novikova, E N Aleksandrova, M V Cherkasova, E L Nasonov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2013-11-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/1151 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adipocytokines in early rheumatoid arthritis: relationship to pro- and anti-inflammatory markers
by: L. V. Kondratyeva, et al.
Published: (2019-01-01) -
Ihmor necrosis factor-a inhibitors and cardiovascular risk in rheumatoid arthritis
by: Tatiana Valentinovna Popkova, et al.
Published: (2012-12-01) -
Diabetes mellitus and hyperglycemia in patients with rheumatoid arthritis
by: L. V. Kondratyeva, et al.
Published: (2014-09-01) -
TYPE 2 DIABETES MELLITUS RISK ASSESSMENT USING FINDRISC IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: L. V. Kondratyeva, et al.
Published: (2017-10-01) -
Insulin resistance in rheumatoid arthritis: relationship to lipid metabolism disorders and metabolic syndrome
by: L. V. Kondratyeva, et al.
Published: (2019-07-01)